Pharma Guides

Long-form educational guides for pharma + biotech professionals: FDA approval process, PDUFA dates, biosimilars vs generics, accelerated approval, breakthrough therapy, orphan drug designation, patent cliff economics, and more.

Long-form explainers for pharma + biotech concepts that don't fit in a glossary entry. Each guide is reviewed quarterly and links back into the live data on Drug Landscape (calendars, trackers, briefs).

Regulatory

• FDA Approval Process Explained
• What is a PDUFA Date?
• IND Application — Starting Clinical Trials
• Breakthrough Therapy Designation
• Fast Track Designation
• Accelerated Approval Pathway
• Orphan Drug Designation
• NDA vs BLA — Small Molecule vs Biologic
• REMS Programs Explained

Clinical research

• Phase 1 vs Phase 2 vs Phase 3 Trials

Clinical practice

• Off-Label Drug Use

IP + economics

• Biosimilars vs Generics
• Patent Cliff Explained

Economics

• Drug Development Cost

Related

• Pharma glossary — short definitions for 60+ terms
• Editorial policy + sources
• API documentation